Jade Biosciences, Inc. (BOATS:JBIO) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Peter Kolchinsky Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Wave Life Sciences Ltd. (Director · Since at least Aug 14, 2015); Black Diamond Therapeutics, Inc. (Director · Jul 5, 2023 – Jul 5, 2023 · Past); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Research Alliance Corp II (Chief Executive Officer, Director · Mar 17, 2021 – Mar 17, 2021 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Solid Biosciences Inc. (Director · Dec 10, 2020 – Jan 11, 2024 · Past); POINT Biopharma Global Inc (Chief Executive Officer, Director · Jul 7, 2020 – Jun 29, 2021 · Past); Forma Therapeutics Holdings Inc (Director · Jun 18, 2020 – Jun 8, 2022 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 3, 2022 · Past); Synthorx Inc (Director · Dec 6, 2018 – Jan 23, 2020 · Past); Kala Bio, Inc. (Director · Oct 3, 2018 – Mar 13, 2020 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – Jun 19, 2018 · Past); KalVista Pharmaceuticals, Inc. (Director · Oct 12, 2017 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Jun 20, 2017 – Apr 2, 2020 · Past); Dicerna Pharmaceuticals Inc (Director · Jan 29, 2014 – Nov 27, 2019 · Past) | Director · Jun 29, 2021 – Jun 17, 2024 · Past |
| Rajeev M Shah Other companies: Freenome, Inc. (Director · Since at least Jul 20, 2026); Parabilis Medicines, Inc. (Director · Since at least Jun 9, 2026); Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Evommune, Inc. (Director · Since at least Nov 5, 2025); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Septerna, Inc. (Director · Since at least Oct 24, 2024); Bicara Therapeutics Inc. (Director · Since at least Sep 12, 2024); Artiva Biotherapeutics, Inc. (Director · Since at least Jul 18, 2024); Cidara Therapeutics Inc (Director · Since at least Apr 24, 2024); LENZ Therapeutics, Inc. (Director · Since at least Mar 21, 2024); Mineralys Therapeutics, Inc. (Director · Since at least Feb 9, 2023); Acrivon Therapeutics, Inc. (Director · Since at least Nov 9, 2022); ARS Pharmaceuticals, Inc. (Director · Since at least Nov 8, 2022); PepGen Inc. (Director · Since at least May 5, 2022); Nkarta, Inc. (Director · Since at least Feb 14, 2022); Tyra Biosciences, Inc. (Director · Since at least Sep 14, 2021); Wave Life Sciences Ltd. (Director · Since at least Aug 16, 2021); Climb Bio, Inc. (Director · Since at least Aug 9, 2021); Acumen Pharmaceuticals, Inc. (Director · Since at least Jun 30, 2021); Janux Therapeutics, Inc. (Director · Since at least Jun 10, 2021); Vor Biopharma Inc. (Director · Since at least Feb 4, 2021); 89bio Inc (Director · Since at least Nov 8, 2019); Iteos Therapeutics Inc (Director · Jun 9, 2022 – Jun 9, 2022 · Past); Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Jun 8, 2022 · Past); Icosavax Inc (Director · Jul 28, 2021 – Feb 19, 2024 · Past); Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Mar 14, 2022 · Past); POINT Biopharma Global Inc (Director · Jun 23, 2021 – Jun 29, 2021 · Past); Werewolf Therapeutics, Inc. (Director · Apr 29, 2021 – May 12, 2025 · Past); Orchard Therapeutics PLC (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jul 5, 2023 · Past); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 6, 2023 · Past); Eidos Therapeutics Inc (Director · Jun 19, 2018 – May 27, 2020 · Past); Solid Biosciences Inc. (Director · Jan 25, 2018 – Jan 11, 2024 · Past); Kala Bio, Inc. (Director · Jul 19, 2017 – Jun 17, 2021 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Oct 12, 2017 · Past); Ra Pharmaceuticals Inc (Director · Oct 25, 2016 – Apr 2, 2020 · Past) | Director · Jun 29, 2021 – Jun 17, 2024 · Past |
| Peter Harwin Other companies: Alaunos Therapeutics, Inc. (Founding Partner, Fairmount Funds Management LLC · Since at least Oct 13, 2026); Damora Therapeutics, Inc. (Chairman of the Board · Since at least Nov 10, 2025); Crescent Biopharma, Inc. (Chair of Board · Since at least Jun 13, 2025); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); Spyre Therapeutics, Inc. (Director · Since at least Jun 22, 2023); Cogent Biosciences, Inc. (Founding Partner, Fairmount Funds Management LLC · Since at least Jul 6, 2020); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – Jan 22, 2024 · Past); Viridian Therapeutics, Inc. (Director · Oct 27, 2020 – Jun 26, 2024 · Past) | Director · Since at least Apr 28, 2025 |
| Habib Joseph Dable Other companies: Tyra Biosciences, Inc. (Board Member · Since at least Apr 16, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Relay Therapeutics, Inc. (Director · Since at least Nov 4, 2025); Day One Biopharmaceuticals Inc (Director · Since at least Jan 17, 2024); PepGen Inc. (Non-Executive Director · Since at least Sep 20, 2022); Blueprint Medicines Corp (Director · Since at least Jun 23, 2022); Albireo Pharma Inc (Director · Aug 8, 2022 – Mar 2, 2023 · Past); Tempest Therapeutics, Inc. (Director · Dec 7, 2018 – Jun 22, 2020 · Past); Acceleron Pharma Inc (CEO and President, Director · Dec 1, 2016 – Nov 19, 2021 · Past) | Director · Jul 10, 2023 – Jun 5, 2024 · Past |
| Eric Dobmeier Other companies: Janux Therapeutics, Inc. (Director · Since at least Jul 19, 2024); Structure Therapeutics, Inc. (Director · Since at least Feb 2, 2023); Aduro Biotech Inc (President, CEO, Director · Oct 5, 2020 – Aug 11, 2023 · Past); Adaptive Biotechnologies Corporation (Director · Jun 26, 2019 – Feb 14, 2021 · Past); Aravive Inc (Director · May 25, 2017 – Dec 20, 2017 · Past); Atara Biotherapeutics, Inc. (Director · Mar 26, 2015 – Nov 10, 2023 · Past); Stemline Therapeutics Inc (Director · Jan 28, 2013 – Jun 19, 2017 · Past); Seagen Inc (Chief Operating Officer · Jan 31, 2006 – Dec 4, 2017 · Past) | Director · Since at least Apr 28, 2025 |
| Tomas Kiselak Other companies: Cyclerion Therapeutics, Inc. (Chairman · Since at least Apr 1, 2026); Crescent Biopharma, Inc. (Director · Since at least Jun 13, 2025); Zenas BioPharma, Inc. (Director · Since at least Sep 12, 2024); Oruka Therapeutics, Inc. (Director · Since at least Aug 29, 2024); Apogee Therapeutics, Inc. (Director · Since at least Jul 13, 2023); Spyre Therapeutics, Inc. (Director · Since at least Jun 22, 2023); Viridian Therapeutics, Inc. (Director · Since at least Oct 27, 2020); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – Sep 27, 2024 · Past) | Director · Since at least Apr 28, 2025 |
| Mark Iwicki Other companies: Inhibikase Therapeutics, Inc. (Chief Executive Officer - Inhibikase · Since at least Feb 14, 2025); Q32 Bio Inc. (Director · Since at least Mar 25, 2024); Third Harmonic Bio Inc. (Director · Since at least Sep 14, 2022); Akero Therapeutics Inc (Director · Since at least Jun 19, 2019); Kala Bio, Inc. (Director · Since at least Jul 19, 2017); Pulmatrix, Inc. (Director · Mar 20, 2017 – Jan 28, 2021 · Past); Aimmune Therapeutics Inc (Director · May 25, 2016 – Oct 10, 2020 · Past) | Director · Apr 2, 2021 – Jun 5, 2024 · Past |
| Joshua Resnick Other companies: Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Cidara Therapeutics Inc (Director · Since at least Jan 3, 2025); PepGen Inc. (Director · Since at least May 5, 2022); Vor Biopharma Inc. (Director · Feb 4, 2021 – May 22, 2025 · Past); Tectonic Therapeutic, Inc. (Director · Jun 20, 2018 – Jun 20, 2018 · Past); KalVista Pharmaceuticals, Inc. (Director · Nov 21, 2016 – Sep 27, 2017 · Past) | Director · Jun 29, 2021 – Jun 5, 2024 · Past |
| Edward R. Conner Other companies: Ardelyx, Inc. (Chief Medical Officer · Since at least Aug 1, 2025); Third Harmonic Bio Inc. (Chief Medical Officer · Sep 14, 2022 – Jan 15, 2025 · Past); Enliven Therapeutics, Inc. (Director · Apr 22, 2020 – Jun 2, 2022 · Past); Audentes Therapeutics Inc (SVP, Chief Medical Officer · Jul 15, 2019 – Jan 15, 2020 · Past); Sangamo Therapeutics, Inc. (Sr. VP & Chief Medical Officer · Nov 30, 2016 – Jan 24, 2019 · Past) | Chief Medical Officer · Since Apr 22, 2026 |
| Allison Dorval Other companies: Verve Therapeutics Inc (Chief Financial Officer · Since at least Nov 29, 2021); Puma Biotechnology Inc (Director · Since at least Jul 15, 2021); Voyager Therapeutics, Inc. (Chief Financial Officer · Jun 8, 2018 – Mar 19, 2021 · Past); Insulet Corporation (Chief Financial Officer · Nov 6, 2014 – Apr 1, 2015 · Past) | Director · Jul 15, 2021 – Jun 5, 2024 · Past |
| Donald J Santel Other companies: Oyster Point Pharma Inc (Director · Jul 30, 2021 – Jan 3, 2023 · Past); Surrozen, Inc. (Director · Nov 18, 2020 – Nov 18, 2020 · Past); Hyperion Therapeutics Inc (CEO & President, Director · Jul 25, 2012 – May 7, 2015 · Past); Anthera Pharmaceuticals Inc (Director · Feb 23, 2010 – Jun 30, 2011 · Past) | Director · Jan 19, 2023 – Jun 5, 2024 · Past |
| Erin Lavelle Other companies: Avalyn Pharma Inc. (Director · Since at least Apr 29, 2026); Neurogene Inc. (Director · May 12, 2022 – Jun 8, 2023 · Past); Climb Bio, Inc. (COO & CFO · Aug 9, 2021 – Oct 31, 2022 · Past); Alder BioPharmaceuticals Inc (Chief Operating Officer · Apr 16, 2018 – Oct 22, 2019 · Past) | Director · Since at least Apr 28, 2025 |
| Lawrence Klein Other companies: Oruka Therapeutics, Inc. (Chief Executive Officer, Director · Since at least Aug 29, 2024); Jasper Therapeutics, Inc. (Director · Sep 24, 2021 – Jun 7, 2023 · Past); Dyne Therapeutics, Inc. (Director · Jul 31, 2020 – Jul 5, 2022 · Past); CRISPR Therapeutics AG (CBO & COO · Jan 2, 2019 – Aug 16, 2022 · Past) | Chief Executive Officer, Oruka Therapeutics · Since at least Apr 28, 2025 |
| Chris Cain Other companies: Damora Therapeutics, Inc. (Board Director · Since at least Nov 10, 2025); Viridian Therapeutics, Inc. (Director · Since at least Mar 10, 2025); Cogent Biosciences, Inc. (Director · Since at least Jul 6, 2020) | Director · Since at least Apr 28, 2025 |
| Mark Eisner Other companies: Zura Bio Limited (Director · Since at least Feb 21, 2026); Vir Biotechnology, Inc. (EVP and Chief Medical Officer · Since at least Jun 3, 2024); Kyntra Bio, Inc. (EVP, Chief Medical Officer · Dec 1, 2020 – Sep 6, 2023 · Past) | Director · Since at least Jun 25, 2026 |
| Bradford D Dahms Other companies: Theseus Pharmaceuticals Inc (President and CFO · Oct 6, 2021 – Feb 14, 2024 · Past); Cartesian Therapeutics, Inc. (Chief Financial Officer · Sep 3, 2019 – Jan 4, 2021 · Past) | Chief Financial Officer · Since at least Jul 14, 2025 |
| David Grayzel Other companies: Q32 Bio Inc. (Director · Since at least Mar 25, 2024); Surface Oncology Inc (Director · Apr 18, 2018 – Sep 8, 2023 · Past) | Director · Feb 1, 2021 – Jun 5, 2024 · Past |
| George A Eldridge Other companies: Protara Therapeutics, Inc. (Sr VP, CFO, Treasr, Asst Secy · Oct 21, 2014 – Jan 18, 2019 · Past); Targanta Therapeutics Corp (CFO,Treasurer & Asst Secretary · Oct 10, 2007 – Feb 6, 2008 · Past) | SEE REMARKS · Apr 2, 2021 – Jun 14, 2024 · Past |
| Maha Katabi Other companies: RayzeBio, Inc. (Director · Sep 14, 2023 – Feb 26, 2024 · Past); Vera Therapeutics, Inc. (Director · May 13, 2021 – May 14, 2025 · Past) | Director · Feb 1, 2021 – Jun 5, 2024 · Past |
| Andrew King Other companies: Aduro Biotech Inc (Chief Scientific Officer · Oct 5, 2020 – Aug 11, 2023 · Past) | President, Research & Development · Since at least Apr 28, 2025 |
| Chris Cain Other companies: Cogent Biosciences, Inc. (Member of the Compensation Committee, Chair of the Science & Technology Committee · Since at least Nov 4, 2026) | Director of Research, Fairmount · Since at least Nov 4, 2026 |
| Elizabeth Bekiroglu Other companies: Icosavax Inc (General Counsel & Corp. Sec. · Sep 21, 2021 – Feb 15, 2023 · Past) | See Remarks · Since at least Apr 28, 2025 |
| Jonathan Quick Other companies: LogicBio Therapeutics Inc (Senior Director-Finance · Jan 1, 2021 – Jan 1, 2021 · Past) | Senior Vice President, Finance · Since at least Apr 28, 2025 |
| Timothy Pigot Other companies: Inhibikase Therapeutics, Inc. (Chief Commercial and Strategy Officer · Since at least Aug 19, 2025) | CHIEF COMMERCIAL OFFICER · Mar 7, 2023 – Jan 22, 2024 · Past |
| Timothy P Noyes Other companies: Protara Therapeutics, Inc. (President and CEO, Director · Oct 21, 2014 – Jan 31, 2019 · Past) | CHIEF EXECUTIVE OFFICER, Director · Apr 2, 2021 – May 16, 2024 · Past |
| Tom Frohlich Other companies: Aduro Biotech Inc (Chief Operating Officer · Oct 5, 2020 – Aug 11, 2023 · Past) | Chief Executive Officer, Director · Since at least Apr 28, 2025 |
| Amy Sullivan | Senior Vice President, Development Operations · Since at least Nov 5, 2026 |
| Benjamin T Dake | SEE REMARKS · Apr 2, 2021 – Jul 31, 2024 · Past |
| Brad Dahms | Chief Financial Officer · Since at least Jul 1, 2025 |
| Elizabeth Balta | Chief Legal Officer & Corporate Secretary · Since at least Nov 5, 2026 |
| Hetal Kocinsky | Chief Medical Officer · Apr 28, 2025 – Apr 28, 2025 · Past |
| Hunter Gillies | CHIEF MEDICAL OFFICER · Apr 2, 2021 – Jun 13, 2024 · Past |
| Lori Stewart | Senior Vice President, People · Since at least Nov 5, 2026 |
| Marinus Verwijs | CHIEF TECHNICAL OFFICER · Mar 21, 2022 – Jun 14, 2024 · Past |
| Ralph Niven | CHIEF SCIENTIFIC OFFICER · Apr 2, 2021 – Feb 5, 2024 · Past |
| Sandy Lewis | Senior Vice President, Biometrics and Clinical Strategy · Since at least Nov 4, 2026 |
| Tom Frohlich | Chief Executive Officer · Since at least Aug 10, 2026 |
| Valerie Fauvelle | Senior Vice President, Regulatory & Quality · Since at least Nov 5, 2026 |